Panagiota‐Christina Georgiou

In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates

Joseph Meletiadis, Paschalis Paranos, Panagiota‐Christina Georgiou et al. · International Journal of Antimicrobial Agents · 2021 · 33 citations

Life Sciences, Infectious Diseases, Microbiology +14

Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023

Maria Siopi, Panagiota‐Christina Georgiou, Paschalis Paranos et al. · Eurosurveillance · 2024 · 29 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Candida auris fungaemia outbreak in a tertiary care academic hospital and emergence of a pan-echinocandin resistant isolate, Greece, 2021 to 2023

Joseph Meletiadis, Maria Siopi, Bram Spruijtenburg et al. · Eurosurveillance · 2024 · 28 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints

Marilena Tsala, Sophia Vourli, Panagiota‐Christina Georgiou et al. · Journal of Antimicrobial Chemotherapy · 2017 · 27 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Activity of Cefepime in Combination with the Novel β-Lactamase Inhibitor Taniborbactam (VNRX-5133) against Extended-Spectrum-β-Lactamase-Producing Isolates in <i>In Vitro</i> Checkerboard Assays

Wendy Kloezen, Ria J. B. Melchers, Panagiota‐Christina Georgiou et al. · Antimicrobial Agents and Chemotherapy · 2021 · 25 citations · Full text

Life Sciences, Microbiology, Pharmacology +17